Research and Markets: Global Refractory Acute Myeloid Leukemia Therapeutics Pipeline Review, H2 2015 - 50 Companies & 117 Drug Profiles

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/fkdlxp/refractory_acute) has announced the addition of the "Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Refractory Acute Myeloid Leukemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with the latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Refractory Acute Myeloid Leukemia and special features on late-stage and discontinued projects.

The report enhances decision-making capabilities and helps to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MoAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development

  • 4SC AG
  • AbbVie Inc.
  • Actinium Pharmaceuticals, Inc.
  • Agios Pharmaceuticals, Inc.
  • Amgen Inc.
  • Astex Pharmaceuticals, Inc.
  • AstraZeneca Plc
  • AVEO Pharmaceuticals, Inc.
  • BioLineRx, Ltd.
  • Boehringer Ingelheim GmbH
  • Boston Biomedical, Inc.
  • Bristol-Myers Squibb Company
  • Calithera Biosciences, Inc.
  • Celgene Corporation
  • Cornerstone Pharmaceuticals, Inc.
  • CTI BioPharma Corp.
  • Daiichi Sankyo Company, Limited
  • Eisai Co., Ltd.
  • EpiZyme, Inc.
  • GlaxoSmithKline Plc
  • Jiangsu Hansoh Pharmaceutical Co., Ltd.
  • JW Pharmaceutical Corporation
  • Karyopharm Therapeutics, Inc.
  • Kyowa Hakko Kirin Co., Ltd.
  • Les Laboratoires Servier SAS
  • MacroGenics, Inc.
  • Merck & Co., Inc.
  • Millennium Pharmaceuticals, Inc.
  • NantKwest, Inc.
  • Novartis AG
  • Otsuka Holdings Co., Ltd.
  • Oxford BioTherapeutics, Ltd.
  • Synta Pharmaceuticals Corp.
  • TaiGen Biotechnology Co., Ltd.
  • Threshold Pharmaceuticals, Inc.

For more information visit http://www.researchandmarkets.com/research/fkdlxp/refractory_acute.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology